Term
|
Definition
Impairs metabolism
Interferes with formation of glucuronide conjugates |
|
|
Term
|
Definition
M3G
M6G- 100x more potent than morphine |
|
|
Term
|
Definition
Onset: 20 mins
Peak: 30-60 mins
Duration of Action 4-6 hour |
|
|
Term
|
Definition
Spasm of biliary smooth muscle- sphincter of Oddi
Constipation, biliary colic, delayed gastric emptying |
|
|
Term
|
Definition
Difficult to void due to relaxation of Detrusor muscle |
|
|
Term
|
Definition
Make sure it is not from histamine release
Cutaneous Vessels Dilate
Bronchoconstriction
May look shocky |
|
|
Term
|
Definition
Can go to fetus and depress neonate
No real barrier from mother to fetus |
|
|
Term
|
Definition
|
|
Term
|
Definition
Onset: 5 min
Peak: 30-60 min
Duration: 2-4 hours |
|
|
Term
Urinary Excretion of Meperidine |
|
Definition
Principal elimination
pH dependent
Renal impairment can cause accumulation |
|
|
Term
|
Definition
Metabolite of Meperidine
Can cause CNS excitation, delirium, Sx |
|
|
Term
Fun Facts about Meperidine |
|
Definition
Atropine like- myodriasis and increased HR
Can cause serotonin syndrome
Crosses placenta
Great for shivering
Less GI effects because it is more like atropine |
|
|
Term
|
Definition
|
|
Term
|
Definition
Onset: 2-5 min
Peak: 20-30 mins
Duration: 30 mins- 1 hr |
|
|
Term
|
Definition
Oralet
ACTIQ
Great for peds and chronic pain |
|
|
Term
|
Definition
25 mcg/hr per 10cm2 of patch
24 hrs for blood to stablize
17 hr 1/2 once d/c
(3 hr actual half life) |
|
|
Term
|
Definition
|
|
Term
|
Definition
8-100 mcgs/kg
Infusion: 0.5-3 mcg/kg/min |
|
|
Term
|
Definition
Onset: Immediate
Peak: Immediate |
|
|
Term
Use Alfentanil Cautiously in Pts with |
|
Definition
Parkinson Disease- decrease central dopamine transmission
Erythromycin- CYP450 impaired, prolongs sedation and respiratory depression |
|
|
Term
|
Definition
0.05-0.3 mcg/kg/min
Loading dose: 1mcg/kg |
|
|
Term
|
Definition
Onset: 1 min
Peak: 1 min
Duration: 5-10 mins |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
Onset: 15-30 min
Peak: 30-90 min
Duration of Action: 4-5 Hours |
|
|
Term
|
Definition
|
|
Term
Opioid Agonist- Antagonists |
|
Definition
Bind to Mu receptors where they produce a limited response or no affect
Exert partial effect on kappa and delta receptors
May cause dysphoria
Provide analgesia with limited respiratory depression
Low potential for dependence
Have ceiling effect |
|
|
Term
|
Definition
Binding affinity is the same for both drugs but maximal elicited response is significantly less for partial agonist |
|
|
Term
Structural formulas of mixed agonist-antagonists |
|
Definition
Mu receptor blockers but agonist at kappa receptors |
|
|
Term
|
Definition
|
|
Term
|
Definition
20-40 mcg IVP
5 mcg/kg/hr Infusion |
|
|
Term
|
Definition
0.25 mcg/kg IV q 2 to 5 mins
Do not exceed 1 mg |
|
|
Term
Opioid Agonists Decrease MAC by |
|
Definition
|
|
Term
Opioid Agonist-Antagonist Decrease MAC by |
|
Definition
|
|